You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
传港府将封锁九龙部分地区 恒指跌幅曾扩至近450点 惟美团/药明生物逆升2%-7%再破顶
阿思达克 01-22 11:37
本港去年12月整体通体通缩加剧至0.7%,远超市场预期跌幅略扩至0.3%,且已连续第六个月呈通缩;期内基本通胀率按年放缓至零增长(前值升0.3%)。累计全年整体通胀率0.3%,基本通胀率1.3%。

据《南华早报》引述消息指,港府有意在本周末起对旧楼及分间房间林立的佐敦及深水(土步)区首次实行封锁,属本年以来最激进措施,以控制疫情。

恒指继昨天反覆高见30,135创廿一个月高後轻微回软结束三连涨後,今早在低开118点或0.4%报29,809,跌幅曾扩至448点,低见29,479喘定,现造29,550,续吐377点或近1.3%,成交额1,321亿元。

蓝筹股普遍跌跌逾1%-2%;因遭美制裁下周二起正式被剔出MSCI明晟全球市场指数和MSCI中国全股票指数的中海油(00883.HK)更续挫5.2%,曾低见7.8元(略失50天线7.81元)。

已连吐两天友邦(01299.HK)、国寿(02628.HK)、万洲(00288.HK)、瑞声(02018.HK)、阿里(09988.HK)、中石油(00857.HK)、吉利(00175.HK)、小米(01810.HK)及银娱(00027.HK)也跌3%-4.5%。

不过,继花旗升价至130元後,建银国际更升药明生物(02269.HK)目标价至140元,料纯利复合增长率逾四成,该股继昨天破顶倒跌後,今天回升7%曾高见128.2元再创纪录高。美团(03690.HK)低开1.4%回落至369.2元获承接,掉头再破顶,最高见387.6元,现造383.4元,续升2.1%。重磅股腾讯(00700.HK)续升1.8%曾见699.5元,暂受制昨天盘中所创纪录高位700元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account